海南医学
海南醫學
해남의학
HAINAN MEDICAL JOURNAL
2014年
18期
2684-2686
,共3页
高子夜%刘晓波%金曙%李胜保%童强
高子夜%劉曉波%金曙%李勝保%童彊
고자야%류효파%금서%리성보%동강
超声胃镜%内镜下多环黏膜切除术%食管黏膜下肿瘤%黏膜层%黏膜下层
超聲胃鏡%內鏡下多環黏膜切除術%食管黏膜下腫瘤%黏膜層%黏膜下層
초성위경%내경하다배점막절제술%식관점막하종류%점막층%점막하층
Endoscopic ultrasonography%Endoscopic muti-band mucosectomy%Esophageal submucosal tu-mor%Mucosa%Submucosa
目的:探讨超声胃镜(EUS)联合内镜下多环黏膜切除术(EMBM)治疗食管黏膜下肿瘤的可行性、安全性及有效性。方法对湖北医药学院附属太和医院消化内镜中心2011年8月至2013年2月收治的经普通胃镜、超声胃镜确诊的35例位于食管黏膜下肿瘤患者行内镜下多环黏膜切除术,标本送病理学检查,术后定期复查胃镜,评估患者疗效。结果35例患者均手术成功。术后病检15例,与内镜活检标本符合率为93.3%(14/15),20例未取检者超声胃镜符合率为95.0%(19/20),超声胃镜总符合率为88.6%,有6例患者出现胸痛,其中2例行内镜下止血,患者无穿孔、感染、梗阻等并发症发生。术后2周复查创面无渗血、渗液,4周创面完全愈合形成疤痕,术后随访6个月~2年无患者复发。结论超声胃镜可以判断食管黏膜下肿瘤起源并初步定性,内镜下多环黏膜切除术操作简便、用时短,超声内镜联合内镜下多环黏膜切除术治疗食管黏膜下肿瘤安全性高、效果好,值得临床推广。
目的:探討超聲胃鏡(EUS)聯閤內鏡下多環黏膜切除術(EMBM)治療食管黏膜下腫瘤的可行性、安全性及有效性。方法對湖北醫藥學院附屬太和醫院消化內鏡中心2011年8月至2013年2月收治的經普通胃鏡、超聲胃鏡確診的35例位于食管黏膜下腫瘤患者行內鏡下多環黏膜切除術,標本送病理學檢查,術後定期複查胃鏡,評估患者療效。結果35例患者均手術成功。術後病檢15例,與內鏡活檢標本符閤率為93.3%(14/15),20例未取檢者超聲胃鏡符閤率為95.0%(19/20),超聲胃鏡總符閤率為88.6%,有6例患者齣現胸痛,其中2例行內鏡下止血,患者無穿孔、感染、梗阻等併髮癥髮生。術後2週複查創麵無滲血、滲液,4週創麵完全愈閤形成疤痕,術後隨訪6箇月~2年無患者複髮。結論超聲胃鏡可以判斷食管黏膜下腫瘤起源併初步定性,內鏡下多環黏膜切除術操作簡便、用時短,超聲內鏡聯閤內鏡下多環黏膜切除術治療食管黏膜下腫瘤安全性高、效果好,值得臨床推廣。
목적:탐토초성위경(EUS)연합내경하다배점막절제술(EMBM)치료식관점막하종류적가행성、안전성급유효성。방법대호북의약학원부속태화의원소화내경중심2011년8월지2013년2월수치적경보통위경、초성위경학진적35례위우식관점막하종류환자행내경하다배점막절제술,표본송병이학검사,술후정기복사위경,평고환자료효。결과35례환자균수술성공。술후병검15례,여내경활검표본부합솔위93.3%(14/15),20례미취검자초성위경부합솔위95.0%(19/20),초성위경총부합솔위88.6%,유6례환자출현흉통,기중2례행내경하지혈,환자무천공、감염、경조등병발증발생。술후2주복사창면무삼혈、삼액,4주창면완전유합형성파흔,술후수방6개월~2년무환자복발。결론초성위경가이판단식관점막하종류기원병초보정성,내경하다배점막절제술조작간편、용시단,초성내경연합내경하다배점막절제술치료식관점막하종류안전성고、효과호,치득림상추엄。
Objective To investigate the feasibility, safety and efficacy of endoscopic ultrasonography (EUS) combined with endoscopic muti-band mucosectomy (EMBM) in the treatment of esophageal submucosal tumor. Methods Thirty-five patients with esophageal submucosal tumors confirmed by ordinary endoscopy, EUS in the digestive endoscopy center of our hospital from Aug. 2011 to Feb. 2013 were treated by EMBM. Spec-imens were sent for pathological examination. Regular postoperative endoscopy was conducted to assess the clini-cal efficacy. Results Thirty-five patients all had successful surgery. Fifteen cases received postoperative pathological examination, with the compliance rate with endoscopic biopsy of 93.3%. For the 20 patients who did not take patho-logical examination, the compliance rate with EUS was 95.0%, and the total EUS compliance rate was 88.6%. Six pa-tients were found chest pain, of which two were performed routine endoscopic hemostasis. No case of perforation, in-fection, obstruction and other complications were observed. The wound was no longer oozing after two weeks and healed completely after four weeks with the formation of scar. No relapse was observed during the follow-up of 6~24 months. Conclusion EUS can determine the origin of esophageal submucosal tumor and and diagnose preliminary. EMBM is easy to operate and need shorter time. EUS combined with EMBM in the treatment of esophageal submuco-sal tumors has high safety and efficiency, which is worthy of promotion.